-
- GOTO Atsuo
- the Department of Internal Medicine, Faculty of Medicine, University of Tokyo
-
- YAMADA Kaoru
- Department of Human Health Care, Sanraku Hospital
この論文をさがす
抄録
It is clear that defective renal sodium handling plays an important role in the development of hypertension and that this abnormality could be caused by heterogeneous hereditary factors in the kidney. It is likely that sodium pump inhibitors with or without whole-body autoregulation gradually produce a rise in blood pressure in response to retained body sodium. Accumulated evidence has suggested that several sodium pump inhibitors similar to cardiotonic steroids are present in the human body. Ouabainlike compound (OLC) has been found to be increased with high sodium intake and hypervolemia, and in essential hypertension, mineralocorticoid hypertension, and pregnancy-induced hypertension. Further, blocking the action of OLC with digibind or a novel anti-ouabain agent has been observed to lower blood pressure in several models of experimental and clinical hypertension. The blockade of OLC action may become the basis of novel rational antihypertensive agents and may help to solve the problems still present in the management of hypertensive patients. (Hypertens Res 2000; 23 Suppl: S7-S13)
収録刊行物
-
- Hypertension Research
-
Hypertension Research 23 (Supplement), S7-S13, 2000
日本高血圧学会
- Tweet
詳細情報
-
- CRID
- 1390282679696034688
-
- NII論文ID
- 10008741397
- 130003456493
-
- NII書誌ID
- AA10847079
-
- COI
- 1:CAS:528:DC%2BD3cXnt1Khu7w%3D
-
- ISSN
- 13484214
- 09169636
-
- PubMed
- 11016813
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可